articleThe LancetMar 29, 2026Closed access

Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial

Amsterdam University Medical Centers · University of Amsterdam · +13 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

4
total citations
FWCI
57.63
Percentile
99%
References
25
Too recent for citation history.

Authors

53

Topics & keywords

Keywords
  • Randomized controlled trial
  • Deferral
  • Percutaneous coronary intervention
  • Intervention (counseling)
  • Percutaneous
  • Cardiac catheterization
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding